TNFRSF10B and cancer: More globally, this antidiabetic drug used as a single treatment or in combination with TRAIL may be a potential chemotherapeutic strategy for cancer in general since it targets several common apoptotic mediators (DR4/DR5, TRAIL, c-FLIP).